Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

BIT's 3rd Annual World Congress and EXPO of Advanced Materials-2014  (WCAM2014)

06 Jun 2014 - 09 Jun 2014 - Chongqing, China

Bookmark and Share

    WCAM-2014 with the Theme of “Dream of Ubiquitous Smartness” will be held at Chongqing Yuelai International Conference & EXPO Center, China during June 6-9, 2014. It is intended to provide a platform for professionals around the world to exchange state-of-the-art research and development and identify research needs and opportunities in this emerging field.
      As the cornerstone of high-tech industry of the twenty-first century, Advanced Materials are even known as the "cradle" of new technologies, new products, and new equipment of all areas in a sense and will create a huge composite materials market on renewable energy. Based on its significance, WCAM will bring about enormous benefits as well as open up a new and broader pathway for information and experience exchange between China and the rest of the world.
        Keynote Speakers:
          Dr. Dan Shechtman, Philip Tobias Professor of Materials Science, Israel Institute of Technology, Israel. The Nobel Prize in Chemistry 2011
            Dr. Navin Manjooran, Global Manager, Siemens Corporation, USA
              Dr. Florian Kongoli, CEO, FLOGEN Technologies Inc., USA
                Dr. Marek Kozlowski,  Professor, Wroclaw University of Technology, Poland
                  Dr. Zhifeng Ren, M. D. Anderson Chair Professor, Department of Physics and TcSUH, University of Houston, USA Top 100 Materials Scientists
                    Dr. Young-Woo Heo, Dean, School of Materials Science and Engineering, Kyungpook National University, Korea Top 100 Materials Scientists

                      Further information
                      Scientific News
                      Atriva Therapeutics GmbH Develops Innovative Flu Drug
                      Highly effective against seasonal and pandemic influenza.
                      New Gene Therapy for Vision Loss From a Mitochondrial Disease
                      NIH-funded study shows success in targeting mitochondrial DNA in mice.
                      Study Removes Cancer Doubt for Multiple Sclerosis Drug
                      Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
                      Self-Propelled Powder to Stop Bleeding
                      UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
                      Five New Genetic Variants Linked to Brain Cancer Identified
                      The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
                      Antibody Treatment Efficacious in Psoriasis
                      An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
                      Predictive Model for Breast Cancer Progression
                      Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
                      Probing the Forces Involved in Creating The Mitotic Spindle
                      Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
                      Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
                      Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
                      Fatty Liver Disease and Scarring Have Strong Genetic Component
                      Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
                      Scroll Up
                      Scroll Down
                      Skyscraper Banner

                      Skyscraper Banner
                      Go to LabTube
                      Go to eposters
                      Access to the latest scientific news
                      Exclusive articles
                      Upload and share your posters on ePosters
                      Latest presentations and webinars
                      View a library of 1,800+ scientific and medical posters
                      2,600+ scientific and medical posters
                      A library of 2,500+ scientific videos on LabTube
                      3,800+ scientific videos
                      Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!